The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients.

Saved in:
Bibliographic Details
Title: The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients.
Authors: Magro, Fernando1,2,3,4,5 (AUTHOR) fm@med.up.pt, Fernandes, Samuel6,7 (AUTHOR), Patita, Marta8 (AUTHOR), Arroja, Bruno9 (AUTHOR), Lago, Paula5,10 (AUTHOR), Rosa, Isadora11 (AUTHOR), Sousa, Helena Tavares de12,13 (AUTHOR), Ministro, Paula5,14 (AUTHOR), Mocanu, Irina8 (AUTHOR), Vieira, Ana8 (AUTHOR), Castela, Joana11 (AUTHOR), Moleiro, Joana11 (AUTHOR), Roseira, Joana12,13 (AUTHOR), Cancela, Eugénia14 (AUTHOR), Sousa, Paula14 (AUTHOR), Portela, Francisco5,15 (AUTHOR), Correia, Luís5,6 (AUTHOR), Moreira, Paula4 (AUTHOR), Dias, Sandra5 (AUTHOR), Afonso, Joana5 (AUTHOR)
Source: Journal of Crohn's & Colitis. Jul2024, Vol. 18 Issue 7, p1102-1112. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:18739946
DOI:10.1093/ecco-jcc/jjae014